stars 1 stars 2 stars 3

Clinical trials take too long. Carelane is the AI-native clinical trial management platform built to change that — for sponsors, CROs, and biotechs who can't afford to wait for legacy CTMS to catch up. Traditional CTMS platforms were built for a slower era. They treat trials as paperwork to be tracked. Carelane treats them as operations to be accelerated. Our platform unifies study startup, site management, document handling, and oversight in one system, with AI agents that take on the repetitive work clinical teams shouldn't be doing manually — always with a human in the loop, always audit-ready. What Carelane does: - AI-native clinical trial management (CTMS) for sponsors, CROs, and biotechs - Faster study startup and site activation - Streamlined eTMF and document workflows - Real-time oversight across studies, sites, and vendors - Built-in compliance with ICH GCP and 21 CFR Part 11 Who we're built for: - Small-to-mid pharma running lean, time-sensitive programmes - Emerging biotech taking their first or second asset into the clinic - CROs that need to move faster without adding headcount - Investigators and sites who want less admin and more science Every day a trial sits in startup or stalls at a site is a day a patient waits. Carelane exists to close that gap. See it in action: www.carelane.io

Carelane Questions

Yannick Boerner is the Chief Executive Officer and Chief Technology Officer of Carelane.

5 people are employed at Carelane.

Top Carelane Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users